<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-74397</identifier>
<setSpec>1130-0108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Endoscopic follow-up of gastric ulcer in a population at intermediate risk for gastric cancer</dc:title>
<dc:description xml:lang="en">Objectives: Primary: to assess the necessity of a second endoscopy with a pathology study to confirm the healing of all gastric ulcers previously diagnosed through endoscopy in a population at intermediate risk for gastric cancer. Secondary: to assess correlation between endoscopic findings and pathology diagnosis. Patients and methods: a prospective analysis of patients diagnosed with gastric ulcer through endoscopy at Hospital General de Ciudad Real (Spain) over three years. We collected demographic, clinical, endoscopic, and pathological data for the first and subsequent endoscopies. We collected at least six biopsies obtained from ulcer margins, and assessed H. pylori infection. Results: Three hundred and two patients were included in this study. H. pylori infection was diagnosed in 173 (57%), and 113 (37%) patients had used NSAIDs. The positive and negative predictive value for malignancy of endoscopic diagnosis regarding ulcer fold, base, and margins were 34 and 97%, respectively. Only one patient was diagnosed with a tumor during the second endoscopy. At the end of follow-up, the etiology of the ulcer was considered as peptic in 276 patients; Crohn's disease-related in one, and neoplastic in 25 patients (21 adenocarcinomas, 4 lymphomas). Conclusions: in an intermediate-risk population for gastric cancer a second endoscopy is not justified for gastric ulcer patients when endoscopy and biopsy results do not suggest malignancy(AU)</dc:description>
<dc:creator>Carpintero, P</dc:creator>
<dc:creator>Olmedo, J</dc:creator>
<dc:creator>Hernández, A</dc:creator>
<dc:creator>Santa, E. de la</dc:creator>
<dc:creator>López, B</dc:creator>
<dc:creator>Domper, A</dc:creator>
<dc:creator>Mañas, M. D</dc:creator>
<dc:creator>Rodríguez, E</dc:creator>
<dc:creator>Lorente, R</dc:creator>
<dc:creator>Albillos, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivos: Primario: valorar la necesidad de una segunda endoscopia con estudio anatomopatológico para confirmar la curación de todas las úlceras gástricas diagnosticadas previamente mediante endoscopia, en una población de riesgo intermedio de cáncer gástrico. Secundario: correlacionar el juicio diagnóstico del endoscopista y el diagnóstico anatomopatológico. Pacientes y métodos: análisis prospectivo de todos los pacientes diagnosticados de úlcera gástrica mediante endoscopia en el Hospital General de Ciudad Real durante tres años. Se recogieron datos demográficos, clínicos, endoscópicos y anatomopatológicos de la primera y sucesivas endoscopias. Se tomaron al menos seis muestras de biopsia del nicho y se valoró la presencia de H. pylori. Resultados: se incluyeron 302 pacientes. Se diagnosticó infección por H. pylori en 173 (57%) y se documentó la toma de AINE en 113 (37%). El valor predictivo positivo y negativo para malignidad del diagnóstico endoscópico atendiendo a los pliegues, fondo y bordes del nicho fue de 34 y 97%, respectivamente. La segunda endoscopia sólo diagnosticó un paciente. Al final del seguimiento, el diagnóstico etiológico fue de 276 casos de úlcera péptica, 1 de úlcera por enfermedad de Crohn y 25 de úlcera neo-plásica (21 adenocarcinomas, 4 linfomas). Conclusiones: en una población de riesgo intermedio de cáncer gástrico, no está indicada la realización sistemática de una segunda endoscopia en pacientes con úlcera gástrica en los que la visión endoscópica y la biopsia del nicho no indican malignidad(AU)</dc:description>
<dc:source>Rev Esp Enferm Dig;101(5): 317-324, mayo 2009. tab</dc:source>
<dc:identifier>ibc-74397</dc:identifier>
<dc:title xml:lang="es">Seguimiento endoscópico de la úlcera gástrica en una población de riesgo intermedio de cáncer gástrico</dc:title>
<dc:subject>^d238^s22012</dc:subject>
<dc:subject>^d238^s22016</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d19237^s22080</dc:subject>
<dc:subject>^d5897^s22036</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d5897^s22053</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d33125</dc:subject>
<dc:subject>^d1731^s22045</dc:subject>
<dc:subject>^d13662^s22080</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d13666^s22080</dc:subject>
<dc:subject>^d29156^s22001</dc:subject>
<dc:subject>^d28625</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d238^s22080</dc:subject>
<dc:subject>^d23973^s22080</dc:subject>
<dc:subject>^d13411^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d19237^s22012</dc:subject>
<dc:subject>^d5897^s22046</dc:subject>
<dc:subject>^d27938^s22020</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d28606</dc:subject>
<dc:type>article</dc:type>
<dc:date>200905</dc:date>
</metadata>
</record>
</ibecs-document>
